by Ed Susman – Orlando, Florida – Researchers said they were surprised to find that prostate cancer patients treated with anticoagulants appear to achieve a longer median overall… read more.
by Eoghan McNeill – Orlando, Florida – When clinicians observe incidental kidney masses, about 78% of the time they are surgically removed – but a new study suggests… read more.
Chronic obstructive pulmonary disease (COPD) and lung cancer are two of the most important smoking-related diseases worldwide, with a huge combined mortality burden.
Magnetic resonance ultrasound fusion biopsy may aid in selection of patients for active surveillance versus aggressivetherapy, new study in The Journal of Urology® reports
Spin and bias exist in a high proportion of published studies of the outcomes and adverse side-effects of phase III clinical trials of breast cancer treatments, according to… read more.
Yet, researchers say lung cancer tests needed when making COPD diagnosis.
Encouraging safety and efficacy data on novel and emerging therapies presented at the 54th Annual Meeting of the American Society of Haematology (ASH) signal an important step forward… read more.
Therapy may be new option for hard-to-treat blood cancer.
Proof-of-concept animal study selected as one of the best presentations at 54th American Society of Hematology Annual Meeting and Exposition.
Data demonstrate superior patient outcomes with B-R in first-line treatment of iNHL and MCL, compared with current standard of care.
Five additional studies presented at the 2012 Quality Care Symposium provided insight on how oncology practices can improve the quality of care they provide.
Unprecedented genomic sequencing of 14 metastatic TNBC patients yields potential drug targets
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
